MEDICAL RECOMMENDATIONS

Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]

National Advisory Committee on ImmunizationImmunization2022Archived document

ASEM documentary overview

Official National Advisory Committee on Immunization document (2022) on “Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]”. NACI recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines: Methods, epidemiology, hybrid immunity, seroprevalence, efficacy, immunogenicity, administration, benefits, safety, adverse events and more.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document